Bandler R, Keay KA, Floyd N, Price J Central circuits mediating patterned autonomic activity during active vs. passive emotional coping. Brain Res Bull. 2000 Sep 1;53(1):95-104. Review.
Cramp FL, McCullough GR, Lowe AS, Walsh DM Transcutaneous electric nerve stimulation: the effect of intensity on local and distal cutaneous blood flow and skin temperature in healthy subjects. Arch Phys Med Rehabil. 2002 Jan;83(1):5-9.
DeSantana JM, Da Silva LF, De Resende MA, Sluka KA Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats. Neuroscience. 2009 Nov 10;1
Johnson M, Martinson M Efficacy of electrical nerve stimulation for chronic musculoskeletal pain: a meta-analysis of randomized controlled trials. Pain. 2007 Jul;130(1-2):157-65. Epub 2007 Mar 23.
Kalra A, Urban MO, Sluka KA Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). J Pharmacol Exp Ther. 2001 Jul;298(1):257-63.
Katch EM Application of transcutaneous electrical nerve stimulation in dentistry. Anesth Prog. 1986 May-Jun;33(3):156-60.
Keay KA, Bandler R Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev. 2001 Dec;25(7-8):669-78. Review.
Lane RD, McRae K, Reiman EM, Chen K, Ahern GL, Thayer JF Neural correlates of heart rate variability during emotion. Neuroimage. 2009 Jan 1;44(1):213-22. doi: 10.1016/j.neuroimage.2008.07.056. Epub 2008 Aug 9. Erratum in: Neuroimage. 2009 Apr 1;45(2):643
Lombardi F, Stein PK Origin of heart rate variability and turbulence: an appraisal of autonomic modulation of cardiovascular function. Front Physiol. 2011 Dec 8;2:95. doi: 10.3389/fphys.2011.00095. eCollection 2011.
Lovibond PF, Lovibond SH The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995 Mar;33(3):335-43.
Monaco A, Sgolastra F, Pietropaoli D, Giannoni M, Cattaneo R Comparison between sensory and motor transcutaneous electrical nervous stimulation on electromyographic and kinesiographic activity of patients with temporomandibular disorder: a controlled cli
Sallam H, McNearney TA, Doshi D, Chen JD Transcutaneous electrical nerve stimulation (TENS) improves upper GI symptoms and balances the sympathovagal activity in scleroderma patients. Dig Dis Sci. 2007 May;52(5):1329-37. Epub 2007 Mar 20.
Sluka KA, Walsh D Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain. 2003 Apr;4(3):109-21. Review.
Stein C, Dal Lago P, Ferreira JB, Casali KR, Plentz RD Transcutaneous electrical nerve stimulation at different frequencies on heart rate variability in healthy subjects. Auton Neurosci. 2011 Dec 7;165(2):205-8. doi: 10.1016/j.autneu.2011.07.003. Epub 20
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
